Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Healthways, Inc. (HWAY): Point72 Discloses New 6.5% Position as Company Considers Strategic Options

For the third quarter of 2014, Healthways, Inc. (NASDAQ:HWAY) reported earnings that were in line with their own guidance and the estimates of analysts, with adjusted earnings per share remaining flat from the third quarter of 2013 at $0.08 per share. Adjusted net earnings meanwhile were up over 11% to $3.0 million from $2.7 million a year ago. Barrington Research has been the most recent analyst to rate stock, initiating coverage of it on January 22 with an ‘Outperform’ rating and $25 price target.

While the financial data and potential for growth is strong, it’s likely Point72 took interest in Healthways, Inc. (NASDAQ:HWAY) following the company’s press release and Form 8-K filed with the SEC on January 25, in which they disclosed that they were exploring strategic alternatives to increase shareholder value, and that the company’s board has retained the services of J.P. Morgan Securities LLC as its financial advisor to assist in evaluating such opportunities. While not explicitly stated in the press release, it’s possible one such option would be the sale of the company. Healthways, Inc. (NASDAQ:HWAY) did however warn that there is no guarantee that the board will end up taking any action, and that further information relating to their efforts would not be disclosed until such action is taken, or they complete their review without action.

Activity from the hedge funds we track was relatively bearish on Healthways in the third quarter, and rightfully so, as the stock slumped more than 10% between July 1 and November 28. However it’s up over 32% since then, and has been consistently achieving 52-week highs throughout the month of January. It is now attracting admiring gazes from some of the top investment minds in the business as a result, including Cohen’s. Other hedge funds we track with investments in Healthways, Inc. (NASDAQ:HWAY) include Conor Laughlin’s North Tide Capital with 3.85 million shares, Ross Margolies’ Stelliam Investment Management with 2.53 million shares, and Charles Clough’s Clough Capital Partners with 1.06 million shares.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.